Exploring the ethical complexity of pediatric organ transplant candidates and COVID‐19 vaccination: Tensions between autonomy and beneficence, children and parents
Background POT is emotionally sensitive due to cohort vulnerability, their lack of decisional capacity, and waitlist mortality. The COVID‐19 pandemic has added complexity to the setting of pediatric transplantation, as well as living donation, due to tensions about COVID‐19 vaccination for recipient...
Saved in:
Published in | Pediatric transplantation Vol. 27; no. 1; pp. e14408 - n/a |
---|---|
Main Authors | , |
Format | Journal Article |
Language | English |
Published |
Denmark
Wiley Subscription Services, Inc
01.02.2023
John Wiley and Sons Inc |
Subjects | |
Online Access | Get full text |
Cover
Loading…
Summary: | Background
POT is emotionally sensitive due to cohort vulnerability, their lack of decisional capacity, and waitlist mortality. The COVID‐19 pandemic has added complexity to the setting of pediatric transplantation, as well as living donation, due to tensions about COVID‐19 vaccination for recipients, donors, and parent‐caregivers.
Methods
In the context of COVID‐19 vaccination, two ethicists present four pediatric donation and transplant dilemmas for ethical exploration and offer guidance to clinical teams, noting that mandates are controversial, and there is no global harmonization regarding requirements.
Results
As with all vaccinations, they are a tool of organ stewardship aimed to optimize outcomes and, in the setting of pediatrics, ensure optimal caregiving for these vulnerable recipients. Current evidence supports the ethical permissibility of COVID‐19 vaccination mandates for transplant candidates aged 6 months and older.
Conclusion
Our guidance considers the tensions of autonomy and beneficence and the ethical duty of organ stewardship. The harms of being unvaccinated and risking the harms of COVID‐19 and long‐COVID post‐transplant support the ethical permissibility of vaccination mandates in countries where the vaccine has pediatric regulatory approval. |
---|---|
Bibliography: | ObjectType-Article-1 SourceType-Scholarly Journals-1 ObjectType-Feature-2 content type line 23 |
ISSN: | 1397-3142 1399-3046 |
DOI: | 10.1111/petr.14408 |